Berkshire Asset Management’s Guardant Health GH Stock Holding History

Berkshire Asset Management’s Portfolio GH Stock Details GH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-4,972	Closed	-$329K	–	229
2022 Q1	$329K	Sell	4,972 -1,420	-22%	-$97.2K	0.02%	169
2021 Q4	$639K	Sell	6,392 -827	-11%	-$85.5K	0.04%	148
2021 Q3	$902K	Buy	7,219 +354	+5%	+$42.1K	0.06%	119
2021 Q2	$853K	Buy	6,865 +262	+4%	+$35.2K	0.06%	125
2021 Q1	$1.01M	Hold	6,603	–	–	0.07%	115
2020 Q4	$851K	Buy	6,603 +3,887	+143%	+$447K	0.07%	122
2020 Q3	$304K	Buy	2,716 +131	+5%	+$12K	0.03%	138
2020 Q2	$210K	Sell	2,585 -3,280	-56%	-$264K	0.02%	158
2020 Q1	$408K	Buy	+5,865	New	+$450K	0.04%	136

Other funds holding GH

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Berkshire Asset Management's GH Position: Q2 2022 in Review

Berkshire Asset Management sold out of Guardant Health (GH) in Q2 2022, closing a stake of 4,972 shares — an estimated $329K sold.

Berkshire Asset Management first reported a position in GH in Q1 2020 and held it in 9 quarters. The position peaked at $1.01M in Q1 2021. 332 funds tracked by Wall St. Rank hold GH as of Q2 2022.

Berkshire Asset Management reported no remaining Guardant Health position as of Q2 2022 after selling out during the quarter.
Berkshire Asset Management sold 4,972 Guardant Health shares in Q2 2022, an estimated $329K.
Berkshire Asset Management first reported a position in Guardant Health in Q1 2020 and held it in 9 quarters.
Berkshire Asset Management's Guardant Health position peaked at $1.01M in Q1 2021.
332 funds tracked by Wall St. Rank held Guardant Health as of Q2 2022.

Based on Berkshire Asset Management's 13F filing for Q2 2022, filed 12 Aug 2022.